文献速递主动脉疾病

加拿大与美国腹主动脉瘤修复直径阈值的差异

Thresholds for abdominal aortic aneurysm repair in Canada and United States.
PubMed 文献 · J Vasc Surg · 2021-09-29

基于血管质量倡议(VQI)2010–2019年数据,比较加拿大与美国择期腹主动脉瘤修复的实践差异。美国患者中低于推荐直径阈值修复的比例显著更高(38.8% vs 15.2%),但两国围手术期和1年死亡率相似。

要点

  • 美国腹主动脉瘤修复低于推荐直径阈值的比例显著高于加拿大(38.8% vs 15.2%)。
  • 美国血管腔内修复比例更高(83.7% vs 68.4%),部分解释阈值差异。
  • 尽管修复阈值不同,两国院内及1年死亡率相似。

核心结论

  • 加拿大与美国在腹主动脉瘤修复管理上存在显著差异,美国更多患者低于推荐直径阈值接受修复,但围手术期和1年死亡率相似。

研究设计与样本

  • 基于血管质量倡议(VQI)数据库的回顾性队列研究,纳入2010–2019年加拿大与美国择期腹主动脉瘤修复患者,美国51,455例,加拿大1,451例。

主要发现

  • 美国血管腔内修复比例更高(83.7% vs 68.4%;OR 2.38,95%CI 2.13-2.63,P<.001)。
  • 美国患者合并症更多,包括高血压、充血性心力衰竭、慢性肾脏病和既往血运重建。
  • 低于推荐阈值修复的比例美国显著更高(38.8% vs 15.2%;OR 3.57,95%CI 3.03-4.17,P<.001),校正后仍显著(校正OR 3.57,95%CI 2.63-4.17,P<.001)。
  • 预测低于阈值修复的因素包括美国地区(校正OR 3.57,95%CI 3.03-4.17)、男性(校正OR 2.89,95%CI 2.72-3.07)和血管腔内修复(校正OR 2.08,95%CI 1.95-2.21)。
  • 院内死亡率低(1.0% vs 0.8%),1年死亡率两国相似(HR 0.96,95%CI 0.70-1.31,P=.79)。

关键数值与推荐

  • 推荐直径阈值:男性<5.5 cm,女性<5.0 cm。
  • 低于阈值修复比例:美国38.8%,加拿大15.2%。
  • 血管腔内修复比例:美国83.7%,加拿大68.4%。

临床怎么用

  • 血管外科医生应关注腹主动脉瘤修复的直径阈值依从性,尤其在美国实践中低于阈值修复较普遍。
  • 血管腔内修复的广泛使用可能促使低于阈值干预,需结合指南审慎选择患者。

局限性

  • 研究为回顾性观察性设计,仅纳入VQI站点,可能存在选择偏倚。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies have demonstrated significant geographic variations in the management of abdominal aortic aneurysms (AAA) despite standard guidelines. Differences in patient selection, operative technique, and outcomes for AAA repair in Canada versus United States were assessed. METHODS: The Vascular Quality Initiative was used to identify all patients who underwent elective endovascular or open AAA repair between 2010 and 2019 in Canada and the United States. Demographic, clinical, and procedural characteristics were recorded and differences between countries were assessed using independent t test and χ2 test. The primary outcome was the percentage of AAA repaired below recommended diameter thresholds (men, <5.5 cm; women, <5.0 cm). The secondary outcomes were in-hospital and 1-year mortality rates. Associations between region and outcomes were assessed using univariate/multivariate logistic regression and Cox proportional hazards analysis. RESULTS: There were 51,455 U.S. patients and 1451 Canadian patients who underwent AAA repair in Vascular Quality Initiative sites during the study period. There was a higher proportion of endovascular repairs in the United States (83.7% vs 68.4%; odds ratio [OR], 2.38; 95% confidence interval [CI], 2.13-2.63; P < .001). U.S. patients had more comorbidities, including hypertension, congestive heart failure, chronic kidney disease, and prior revascularization. The percentage of AAA repaired below recommended thresholds was significantly higher in the United States (38.8% vs 15.2%; OR, 3.57; 95% CI, 3.03-4.17; P < .001). This difference persisted after controlling for demographic, clinical, and procedural characteristics (adjusted OR, 3.57; 95% CI, 2.63-4.17; P < .001). Factors that predicted AAA repair below recommended thresholds were U.S. region (adjusted OR, 3.57; 95% CI, 3.03-4.17), male sex (adjusted OR, 2.89; 95% CI, 2.72-3.07), and endovascular repair (adjusted OR, 2.08; 95% CI, 1.95-2.21). The in-hospital mortality rate was low (1.0% vs 0.8%) and the 1-year rate mortality was similar between countries (hazard ratio, 0.96; 95% CI, 0.70-1.31; P = .79). CONCLUSIONS: There are significant variations in AAA management between Canada and the United States. A greater proportion of U.S. patients underwent AAA repair below the recommended diameter thresholds. This finding is partly driven by a higher percentage of endovascular repairs. Despite these differences, the perioperative and 1-year mortality rates are similar. Future studies should investigate reasons for these variations and quality improvement projects are needed to standardize care.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Li B, Rizkallah P, Eisenberg N, et al. Thresholds for abdominal aortic aneurysm repair in Canada and United States. J Vasc Surg. 2021. PMID: 34597785. doi:10.1016/j.jvs.2021.08.091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。